Skip to content

News

New Clue in BRCA1 and BRCA2 Mutations

New Clue in BRCA1 and BRCA2 Mutations

A new study released in Lancet Oncology showed that abnormal levels of female hormones in the bloodstream may be why women with BRCA1 or BRCA2 mutations are at a higher risk … Continued

DNA "Tags" Could Guide Treatment

DNA "Tags" Could Guide Treatment

A new study conducted by Cancer Research UK has identified chemical “tags” on DNA in patients’ tumors that could help doctors decide the type of chemotherapy women with advanced ovarian … Continued

Ovarian Cancer News from the European Cancer Congress

Ovarian Cancer News from the European Cancer Congress

The European Cancer Congress convened in Amsterdam, the Netherlands from September 27 – October 1, 2013.  The European Cancer Congress in the main multidisciplinary and multi-professional educational meeting in oncology … Continued

Partner Member Profile: SHARE

Partner Member Profile: SHARE

SHARE got its start in 1976 when Dr. Eugene Thiessen, an oncologist and surgeon, invited survivors to meet informally at the Manhattan breast cancer clinic he founded. “At the time, … Continued

Q&A with Ron Chandler, Ph.D.

Q&A with Ron Chandler, Ph.D.

Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.